Edwards Lifesciences Corp EW
i
Market dataready · fetched 2026-11-12T15:26:34.735Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-11-20
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-12T15:26:31.223610282Z
FundamentalsSEC EDGAR · ready · as of 2026-09-30 · fetched 2026-11-12T15:26:34.207067+00:00
Edwards Lifesciences Corp options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | 108.86 | 24.8% | 4.1% | 100.96 | 30.7% | 4.5% |
| 25Δ | 108.27 | 25.5% | 3.7% | 101.71 | 29.7% | 3.9% |
| 30Δ | 107.68 | 26.2% | 3.4% | 102.46 | 28.6% | 3.4% |
| 35Δ | 107.09 | 27.0% | 3.0% | 103.21 | 27.6% | 2.8% |
| 40Δ | 106.51 | 27.7% | 2.7% | 103.96 | 26.6% | 2.3% |
| 45Δ | 105.92 | 28.4% | 2.3% | 104.71 | 25.6% | 1.7% |
| 50Δ | 105.33 | 29.2% | 1.9% | |||
| 55Δ | 104.67 | 29.8% | 1.6% | |||
| 60Δ | 103.91 | 30.3% | 1.4% | |||
| 65Δ | 103.16 | 30.8% | 1.3% | |||
| 70Δ | 102.40 | 31.3% | 1.1% | |||
| 75Δ | 101.64 | 31.8% | 0.9% | |||
| 80Δ | 100.88 | 32.3% | 0.7% | |||
20Δ
- Pseudo strike
- 108.86
- IV
- 24.8%
- B/E move
- 4.1%
- Pseudo strike
- 100.96
- IV
- 30.7%
- B/E move
- 4.5%
25Δ
- Pseudo strike
- 108.27
- IV
- 25.5%
- B/E move
- 3.7%
- Pseudo strike
- 101.71
- IV
- 29.7%
- B/E move
- 3.9%
30Δ
- Pseudo strike
- 107.68
- IV
- 26.2%
- B/E move
- 3.4%
- Pseudo strike
- 102.46
- IV
- 28.6%
- B/E move
- 3.4%
35Δ
- Pseudo strike
- 107.09
- IV
- 27.0%
- B/E move
- 3.0%
- Pseudo strike
- 103.21
- IV
- 27.6%
- B/E move
- 2.8%
40Δ
- Pseudo strike
- 106.51
- IV
- 27.7%
- B/E move
- 2.7%
- Pseudo strike
- 103.96
- IV
- 26.6%
- B/E move
- 2.3%
45Δ
- Pseudo strike
- 105.92
- IV
- 28.4%
- B/E move
- 2.3%
- Pseudo strike
- 104.71
- IV
- 25.6%
- B/E move
- 1.7%
50Δ
- Pseudo strike
- 105.33
- IV
- 29.2%
- B/E move
- 1.9%
- Pseudo strike
- IV
- B/E move
55Δ
- Pseudo strike
- 104.67
- IV
- 29.8%
- B/E move
- 1.6%
- Pseudo strike
- IV
- B/E move
60Δ
- Pseudo strike
- 103.91
- IV
- 30.3%
- B/E move
- 1.4%
- Pseudo strike
- IV
- B/E move
65Δ
- Pseudo strike
- 103.16
- IV
- 30.8%
- B/E move
- 1.3%
- Pseudo strike
- IV
- B/E move
70Δ
- Pseudo strike
- 102.40
- IV
- 31.3%
- B/E move
- 1.1%
- Pseudo strike
- IV
- B/E move
75Δ
- Pseudo strike
- 101.64
- IV
- 31.8%
- B/E move
- 0.9%
- Pseudo strike
- IV
- B/E move
80Δ
- Pseudo strike
- 100.88
- IV
- 32.3%
- B/E move
- 0.7%
- Pseudo strike
- IV
- B/E move
Options history
Table
| Date | IV (%) |
|---|---|
| 28.13% | |
| 31.26% | |
| 27.13% | |
| 29.23% | |
| 31.32% | |
| 27.75% | |
| 28.54% | |
| 28.08% | |
| 26.73% | |
| 26.61% | |
| 26.81% | |
| 27.27% | |
| 26.83% | |
| 26.74% | |
| 26.06% | |
| 25.92% | |
| 28.61% | |
| 27.73% | |
| 28.52% | |
| 29.37% | |
| 28.87% | |
| 30.72% | |
| 35.27% | |
| 33.71% | |
| 28.85% | |
| 31.13% | |
| 30.12% | |
| 30.36% | |
| 32.54% | |
| 31.39% | |
| 30.71% | |
| 31.17% | |
| 31.20% | |
| 31.89% | |
| 30.67% | |
| 30.24% | |
| 31.61% | |
| 32.08% | |
| 31.32% | |
| 32.21% | |
| 33.89% | |
| 33.55% | |
| 35.35% | |
| 40.13% | |
| 35.16% | |
| 35.03% | |
| 36.01% | |
| 36.18% | |
| 37.09% | |
| 35.74% | |
| 36.78% | |
| 36.88% | |
| 35.50% | |
| 41.80% | |
| 40.14% |
Medical Devices
GEHC
GE HealthCare Technologies Inc. provides medical technology, pharmaceutical diagnostics, and digital solutions in the United States. The company is headquartered in Chicago,…
More →GKOS
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, is focused on developing new therapies for the treatment of glaucoma, corneal disorders, and…
More →GMED
Globus Medical, Inc., a medical device company, develops and markets healthcare solutions for patients with musculoskeletal disorders. The company is headquartered in Audubon,…
More →HAE
Haemonetics Corporation, a healthcare company, offers medical products and solutions. The company is headquartered in Boston, Massachusetts.
More →HYPR
Hyperfine Inc. is a pioneering force in medical technology, renowned for developing the world’s first FDA-cleared portable MRI system, which significantly enhances diagnostic…
More →IART
Description unavailable
More →